May 2026 Research Update

Taken together, these papers suggest that several aortic root surgery approaches used in Marfan syndrome can support long-term survival, but they come with different trade-offs. Valve-sparing operations tended to have more later aortic valve leakage in follow-up, while valve-replacing operations tended to have more bleeding-related events; overall survival and need for another valve procedure were often similar across groups. A separate imaging study raised the possibility that how the aortic root is measured on scans could change how many people appear to meet guideline size thresholds for surgery, but it did not test whether that reclassification better predicts real-world events. [1] [2] [3] [4]

In a prospective cohort of Marfan syndrome patients having valve-sparing root surgery with long follow-up, aortic valve reimplantation and root remodeling were compared, and root remodeling was linked to higher risk of later valve reoperation and moderate or severe valve leakage. Over 25 years, the study reported cumulative risks that included death from any cause, aortic valve reoperation, moderate or severe aortic valve leakage, and new dissections in the downstream (distal) aorta. The same study reported that creating new aortic sinuses using a cylindrical graft was linked to a lower risk of later dissections. [5]

Two multicenter Marfan syndrome cohorts comparing valve-sparing versus valve-replacing root replacement found similar survival overall, but different patterns of complications. One study reported higher aortic valve leakage grades and more annular widening after valve-sparing surgery, and it noted that persistent moderate-or-worse leakage was tied to higher risk of later valve reintervention. Another analysis reported higher rates of structural valve deterioration or dysfunction and moderate-or-worse leakage after valve-sparing surgery, while bleeding was more common after valve-replacing surgery. [1] [2]

A systematic review covering Marfan syndrome and Ehlers-Danlos syndrome described strong long-term survival after both the David valve-sparing procedure and the Bentall procedure, and it reported fewer clotting and bleeding complications with valve-sparing approaches compared with composite valve grafting. The authors emphasized that more multicenter research and the use of imaging and genetic information may help refine how surgical choices are matched to individual patients over time. [3]

One retrospective study looked at two ways to measure aortic root size on computed tomography (CT) scans: Laplace diameter and the conventional sinus-to-sinus diameter. Laplace diameter was larger on average and would have moved more patients across 2022 guideline size thresholds for considering surgery, including within the small Marfan subgroup in this dataset. The study did not include follow-up outcomes like dissection or rupture, so it cannot answer whether the larger measurement method more accurately identifies people at higher risk. [4]

Two reports focused on complex emergency situations where timing and sequencing of procedures mattered. A single-patient case report in Marfan syndrome described a planned three-stage approach for extensive aortic disease and leg blood-flow problems, with an uneventful recovery in that individual. A separate emergency-surgery cohort (mostly non-Marfan) described an approach to treat organ blood-flow problems (such as brain or limb malperfusion) before or during central aortic repair, reporting in-hospital deaths and the use of advanced life support in some patients. [6] [7]

For patients and caregivers, this group of studies mainly helps explain why different surgical options can be discussed even when the shared goal is long-term safety: the operations may have similar survival in some cohorts, but the likely follow-up issues can differ (for example, valve leakage versus bleeding). It also highlights that measurements used to size the aortic root on scans can vary, which may affect whether someone appears to meet guideline thresholds, but it is still uncertain which measurement best matches future real-world risk. The emergency-situation reports provide background on how teams may stage or sequence procedures when blood flow to organs or limbs is threatened, but a single case report cannot predict outcomes for others and the broader cohort included very few Marfan patients. [1] [2] [4] [6] [7]

Across these studies, higher heart and aorta risk was not only about a single measurement, but also about who has stronger inherited patterns and broader Marfan features. In people with aortic dissection, those with a family-linked pattern had more extensive dissection features and more later surgical procedures than people with sporadic dissection, while short-term survival was similar. In children and teens with Marfan syndrome, a higher whole-body feature score and several specific non-heart traits were linked to needing cardiovascular surgery during childhood. [8] [9]

In the International Registry of Acute Aortic Dissection, familial type B aortic dissection made up 8.2% of cases and tended to happen younger than sporadic dissection but older than Marfan-related dissection. Familial cases more often had a prior dissection or prior heart/aorta surgery, and imaging more often showed an open false channel and more extensive dissection; the 3-year rate of later surgical intervention was higher than in sporadic cases (23.78% vs 15.7%). One-year survival was over 93% in all groups. [8]

In a retrospective study of 214 genetically confirmed children and young adults with Marfan syndrome, 9.3% had cardiovascular surgery during childhood. Higher overall systemic involvement (a higher Ghent systemic score) was linked to higher odds of early surgery, and five non-heart features were independently linked to surgery: Marfan-type facial features, pectus carinatum, flat feet, hindfoot deformity, and moderate-to-severe myopia. Tricuspid valve prolapse and pulmonary artery widening were also more common in the group that had surgery. [9]

A cross-sectional analysis of 1,371 records from the Pediatric Heart Network Marfan Study found that aortic root size, main pulmonary artery size, and body size were correlated, especially in children 14 years and younger compared with ages 15 to 26. The strength of these relationships was high and similar in females and males, suggesting age- and sex-related differences in how vessel size relates to body size in Marfan syndrome. [10]

A mouse study tested whether long-lasting high blood pressure could speed up thoracic aorta disease in a Marfan model. Male Marfan mice exposed to induced high blood pressure had more rapid worsening in the ascending aorta and had early death within four weeks (40%), while female Marfan mice and wild-type mice showed less or no similar changes. Because this was animal research, it does not directly show what will happen in people, but it supports the idea that added stress on the aorta may matter and that sex differences could be important. [11]

For patients and caregivers, this set of studies adds context about who may be more likely to face major aorta or heart events within Marfan syndrome and related inherited aortic conditions. The strongest human evidence here is observational, meaning it can point to patterns (family history, broader body features, and certain valve or vessel findings) but cannot prove cause and effect or replace individualized assessment. Some results (like the family-linked dissection pattern and childhood feature patterns) may be relevant now for understanding why clinicians pay attention to family history and whole-body findings, while the mouse study is mainly background research that suggests possible biologic reasons and sex differences that still need confirmation in people.

Across this topic group, the main pattern is that blood vessel problems in Marfan syndrome are not limited to the main aorta. In a large real-world study, aneurysms in other arteries were common and vessel tears were less common; the aneurysms were more often seen in people with markers of more advanced aortic disease. [12]

In 783 people with Marfan syndrome, extra-aortic aneurysms were found in 32%, most often in the iliac arteries (in the pelvis), carotid arteries (in the neck), and subclavian arteries (near the shoulders). Extra-aortic dissections (tears) occurred in 5.2%. [12]

Higher odds of extra-aortic aneurysms were linked to markers of more advanced aortic disease, including an abdominal aortic aneurysm (odds ratio 3.48) and a prior aortic dissection (odds ratio 3.39). Older age (over 40 years) and male sex were also linked to higher risk, while whether genetic testing had confirmed Marfan syndrome was not linked to extra-aortic aneurysm presence. [12]

For patients and caregivers, this study mainly adds context about where Marfan-related blood vessel changes can occur and which situations were tied to higher risk in one large healthcare-based group. It may matter now for understanding why some care teams consider imaging beyond the chest aorta in people with more advanced aortic disease, older age, or male sex, but the study does not by itself prove what the best imaging schedule should be. Uncertainty remains about how often these extra-aortic findings lead to symptoms or procedures, and how best to balance broader imaging with practical issues like cost, access, and follow-up.

These reports show two main diagnostic pitfalls: standard genetic tests can miss certain types of FBN1 changes, and genetic results can be misinterpreted when a variant is wrongly linked to Marfan syndrome. They also show that some children can have Marfan syndrome plus a second genetic condition, which can make the overall picture look unusual and harder to recognize. [13] [14] [15]

In one girl with a clinical diagnosis of Marfan syndrome, routine testing (a multigene aortopathy panel and duo exome sequencing) did not find a cause, but genome sequencing later detected a deletion affecting exons 36-38 in FBN1. The deletion was confirmed with a targeted test that mapped the breakpoints, and it was classified as likely disease-causing, illustrating how copy number variants inside FBN1 may be missed by standard approaches. [13]

A separate report described a child who was labeled with Marfan syndrome after an external test reported a frameshift change in MYH11, even though the child did not meet clinical criteria and had normal heart and eye evaluations. Follow-up work found the variant acted through loss of function with nonsense-mediated decay and was present in healthy relatives, leading the team to withdraw the Marfan diagnosis and emphasize how interpretation and reporting errors can cause unnecessary concern. [14]

Another case described a child with two molecular diagnoses: TYR-related oculocutaneous albinism type 1 and FBN1-related Marfan syndrome. The child had notable eye findings (including high myopia and changes in the back of the eye) along with tall stature and marfanoid traits, showing how coexisting genetic conditions can add extra features that are not usually thought of as part of Marfan syndrome alone. [15]

For patients and caregivers, this body of evidence (three case reports) mainly serves as background about why genetic answers sometimes do not match expectations. It suggests that a negative or unclear routine genetic test may not capture every type of FBN1 change, and that a reported variant in another gene may not actually explain Marfan syndrome if the clinical picture does not fit. It also highlights that, in some situations, having more than one genetic condition can make symptoms and test results harder to interpret, and these individual cases do not indicate how often these situations occur.

Across this group of research, the main pattern was that the gene behind congenital lens dislocation (ectopia lentis) helped explain how severe the eye findings were and how surgeons chose to fix an artificial lens (intraocular lens) during surgery. Differences were seen both between FBN1-related disease (often tied to Marfan syndrome) and non-FBN1 causes, and also among different types of FBN1 variants, suggesting genetic results can add context to pre-surgery eye measurements. [16]

In a retrospective real-world cohort from one center, people with non-FBN1 gene variants had more severe lens dislocation and more front-of-the-eye (anterior segment) problems, such as microspherophakia (a smaller, rounder lens) and iris abnormalities. In the same study, surgeons more often used stronger intraocular lens fixation approaches in the non-FBN1 group (78.95% vs 27.84%). [16]

Within the FBN1 group, certain variant categories were linked to different eye measurements that can matter for surgical planning, including eye length and corneal thickness. The study also reported that a corneal curvature measure helped distinguish patterns that fit one genetic group versus another (area under the curve 0.80), suggesting routine eye measurements may sometimes hint at the underlying genetic cause. [16]

For patients and caregivers, this research mainly adds background context for why two people with lens dislocation may have different eye features and why surgeons may choose different ways to secure an artificial lens. The study supports the idea that genetic testing results and detailed eye measurements can complement each other when describing risk and planning, but it did not report long-term outcomes after surgery, so it cannot say which fixation approach leads to better vision or fewer complications over time. [16]

Across these three case reports (one patient each), Marfan syndrome was linked to urgent situations that required fast recognition and specialized procedures. Two reports focused on successful, image-guided or minimally invasive surgical management with smooth recovery, while one report highlighted rapid bedside imaging to identify a suspected aortic emergency when the patient was in shock. [17] [18] [19]

One 26-year-old woman developed a rare pelvic-area hernia (obturator hernia) causing groin pain, which was diagnosed on a CT scan and repaired laparoscopically with mesh. She recovered without complications and had no hernia recurrence reported at 14 months. [17]

One 30-year-old woman had a fragment of a spinal catheter retained inside the lining around the spinal cord after major aortic surgery, and imaging was used to precisely locate it. A fluoroscopy-guided procedure removed the fragment with minimal nerve handling, and there were no reported neurologic problems or other complications afterward. [18]

One 43-year-old man with prior ascending aortic surgery presented in shock, and focused bedside heart ultrasound showed a widened ascending aorta and a moving flap consistent with a Stanford type A aortic dissection, along with moderate-to-severe aortic valve leakage. He was urgently transferred for cardiac surgery care, but his outcome after transfer was not reported. [19]

For patients and caregivers, these reports mainly serve as background information that Marfan syndrome can show up in urgent care settings in more than one way, including non-heart emergencies (like hernias) and complications related to major procedures (like retained catheter fragments), as well as sudden aortic problems. Because each paper describes only one person, it is not possible to know how often these events happen or which patients are most at risk, but the reports show how imaging and specialized surgical approaches were used in real-world emergencies. [17] [18] [19]

Across this group of papers, researchers mapped out several biological pathways that may shape Marfan syndrome complications, especially in the aorta. Most results come from lab-grown human cells or mouse models, so they mainly help explain what might be driving disease and what future treatment ideas could be tested. One population study added information about cancer risk patterns in Marfan syndrome. [20] [21] [22] [23] [24]

In a cell model using patient-derived stem cells turned into vascular smooth muscle cells (the muscle cells that help the aorta stay strong and flexible), lower levels of the protein HSPB7 were linked to cells shifting away from a normal contractile state and showing other disease-like changes. Increasing HSPB7 in these patient-derived cells reduced several of these abnormal features and pushed the cells back toward a more contractile pattern. [20]

In Marfan syndrome mice, the fat tissue that sits around blood vessels (perivascular fat) changed how strongly the thoracic aorta contracted, and the direction and size of the effect varied by aortic region and by sex. The study pointed to nitric oxide signaling and oxidative stress pathways as important for these effects, including higher Nox4 levels in the perivascular fat from Marfan mice. Blocking certain reactive oxygen or nitrogen signals removed the fat tissue's ability to dampen contractions, supporting a role for redox signaling. [21]

A computational model built from Marfan mouse data simulated how ascending aortic aneurysms may grow and remodel over time and then ran computer-based treatment trials. The model predicted four potential treatments that could lower long-term failure risk, with p38 MAP kinase inhibition highlighted as the strongest predicted option in the simulations; this was not a test in people. [22]

Beyond the aorta, one Marfan mouse study found sex-dependent differences in femur shape and inferred stiffness: males showed more inner bone expansion with thinner cortex and lower bending rigidity, while females maintained or exceeded control rigidity despite geometric changes. The authors noted that the work did not measure bone material properties directly, so how these geometry changes translate to bone strength remains uncertain. [23]

In a nationwide Swedish matched cohort (1,544 people with Marfan syndrome), overall adult cancer risk was similar to the general population (hazard ratio 1.00). The study did find higher risk of endocrine tumors in adults (hazard ratio 2.86) and more than doubled cancer risk in children (hazard ratio 2.44). [24]

For patients and caregivers, these studies mostly add background about what may be happening inside the body (for example, changes in aortic muscle cells, signaling from fat around the aorta, and specific stress-response pathways) that could guide future drug development, but they do not establish new treatments for current care. The cancer study is more directly informative for understanding risk patterns at a population level, although it does not explain why the risks differ by age or tumor type. Many uncertainties remain because several results come from models (cells, mice, or computer simulations) that may not fully match human Marfan syndrome.